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Conclusion Telemedicine had been shown to be a safe and
effective method in the care of stable cardiology patients. The
social, economic and environmental benefit of tele-consultation
raised exciting opportunity for future service designs. Collabo-
ration between hospital specialist, management team, commun-
ity health providers and communication service suppliers are
vital to ensure the sustainable implementation of telemedicine
in cardiology.
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Introduction Patients who experience frequent atrial high
rate episodes (AHREs), recorded on implantable cardiac
devices, are at an increased risk of stroke and systemic
embolism. Increased duration of AHRE is related to higher
risk of thromboembolic event. The underlying pathophysiol-
ogy is unclear; however, autonomic and/or endothelial dys-
function may contribute. We tested the hypothesis that
patients with high AHRE burden have worse autonomic and
vascular function compared to patients with low AHRE
burden.
Methods We studied 44 patients split in two groups: high
AHRE burden (longest AHRE ≥ 24 hours; n = 22) and low
AHRE burden (longest AHRE < 24 hours; n = 22). Resting
time- and frequency-domain measures of HRV were deter-
mined to index cardiac autonomic function. High-resolution
ultrasound was used to measure brachial artery diameter at
rest and during reactive hyperaemia (endothelium-dependent
flow mediated dilation (FMD)).
Results FMD was higher in the low AHRE burden group
compared to high AHRE group (5.5% [95% confidence inter-
val (CI):3.4–7.6] vs 3.1% [95% CI:1.9–6.2]; p=0.04) (table
1). Mean heart rate (p<0.001) and AHRE burden (p=0.02)
were independent predictors of FMD on multivariate analysis.
Time-domain, frequency-domain and non-linear indices of
HRV were not significantly different between the groups. BMI
was an independent predictor of HRV on stepwise multivariate
analysis (p=0.002).
Conclusion Endothelium-dependent FMD is impaired in
patients with high AHRE burden, while HRV derived indices
of autonomic function were not affected by AHRE burden.
Endothelial dysfunction may play an important role in the
adverse outcomes seen in patients who experience frequent
AHRE.
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Background An integrated structured approach to atrial fibril-
lation (AF) management is recommended by ESC.1 However,
limited data is available on its ‘real-world’ impact on anticoa-
gulation uptake and subsequent AF-related hospitalisation and
stroke rates.
Purpose To evaluate the long-term impact of the introduction
of a community-wide integrated AF service based in a secon-
dary care hospital.
Methods In September 2017 we implemented a new integrated
pathway for patients with newly diagnosed ‘symptomatic’
atrial arrhythmias across two regions (population 450,000) in
England in collaboration with primary care. All patients were
seen in a one-stop multi-professional clinic (Arrhythmia nurse
and Electrophysiologist with ECG and echocardiogram) within
2 weeks. They underwent standardised screening for modifi-
able risk factors, counselling regarding diagnosis/ anticoagula-
tion and received an individualised AF management plan as
well as access to a nurse-led telephone helpline. We followed
up the first 126 consecutive patients for a period of 12
months.
Results Baseline characteristics are shown in table 1, showing
a high incidence of modifiable risk factors (previously un-iden-
tified in the majority). After review in clinic, 30-day AF-
related readmission rates to hospital were low (1.6%, n=2) as
compared to historical local data (5.8%). This was sustained
at 3 months (4.7%, n=6) and at 12 months (7.9%, n=10).
99% of 83 of eligible patients (CHA2DS2-VASc score of >2
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Age, years 74.5 [67.5 – 81] 72 [60.8 – 82.8] 0.56
Sex (males/females) 15/7 19/3 0.15
CHA2DS2-VASc score 3 ± 2 3 ± 2 0.93
BMI (kg/m2) 29.6 [26.9 – 32.9] 27.7 [24.8 – 36.7] 0.70
Heart rate (bpm) 69 [61 – 75] 68 [60 – 80] 0.97
Systolic BP (mm/Hg) 152 ± 18 135 ± 17 0.003
Ejection fraction (%) 59 [55 – 62] 55 [40 – 58] 0.009
Baseline diameter (mm) 4.6 [4.3 – 5.0]a 4.8 [4.5 – 5.2]a 0.36
Absolute FMD change (mm) 0.2 [0.2 – 0.4]b 0.1 [0.1 – 0.3]b 0.07
FMD (%) 5.5 [3.4 – 7.6]b 3.1 [1.9 – 6.2]b 0.04
Shear rate stimulus [sec.-1] 5592 [4174 – 9815]b 4173 [2458 – 10547]b 0.41
SDNN (ms) 41 [28 – 55]a 60 [39 – 80]a 0.12
rMSSD (ms) 40 [27 – 54]a 58 [39 – 77]a 0.10
pNN50 (%) 5 [2 – 23]b 17 [2 – 60]b 0.12
LF (ms2) 575 [137 – 1013]a 665 [-264 – 1593]a 0.83
HF (ms2) 160 [66 – 687]b 112 [42 – 1839]b 0.98
LF normalised/HF normalised 0.8 [0.5 – 1.0]b 0.9 [0.5 – 1.4]b 0.84
SD1 (ms) 29 [19 – 38]a 41 [28 – 54]a 0.11
SD2 (ms) 49 [31 – 67]a 67 [47 – 87]a 0.15
Descriptive data are presented as numbers (withpercentages). Normallydistributed data are
expressed as mean [95% confidence intervals (CI)]. Identifiedby superscript a. Non-normally
distributed data are displayed as median [95%CI]. Identified by superscript b. Statistical dif-
ferences were tested usingindependent t-test (for parametric data) or Mann-Whitney U test
(for non-parametricdata). Significancep £0.05
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